How People Voted
6% For, 94% Against
Take Action
![]() ![]() |
Alert Your Friends and Colleagues |
![]() ![]() |
Write Your Representative in Congress |
| Save & Share | |
| del.icio.us | |
| Digg | |
| Yahoo! | |
H.R. 3061, The Medicare Part D Drug Class Protection Act of 2007
- This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
Version saved on July 30, 2007, 18:21:50, by webmaster:
H.R. 3061 would amend title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories, to establish protective requirements for coverage determinations, reconsiderations, and appeals related to such drugs, and to require annual reports on such determinations, reconsiderations, and appeals.
Detailed Summary
Medicare Part D Drug Class Protection Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in six specified therapeutic categories.
Sets forth special requirements for reconsideration of coverage determinations, and appeals for drugs included in such categories.
Establishes reporting requirements for drugs in these categories.
Status of the Legislation
Latest Major Action: 7/17/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Points in Favor
(Log in to edit the wiki and be the first to show why the bill should pass!)
Points Against
(Log in to edit the wiki and be the first to show why the bill should not pass!)
Learn More
RSS Feeds for This Bill
Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)




Visitor Comments
There are currently no comments for this bill.